As of March 2024 Agile Therapeutics has a market cap of $1.09 Million. This makes Agile Therapeutics the world's 8362th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.09 M | -77.61% |
2023 | $4.89 M | -46.88% |
2022 | $9.21 M | -84.44% |
2021 | $59.25 M | -76.39% |
2020 | $0.25 B | 43.78% |
2019 | $0.17 B | 781.54% |
2018 | $19.79 M | -78.47% |
2017 | $91.96 M | -43.9% |
2016 | $0.16 B | -24.74% |
2015 | $0.21 B | 90.35% |
2014 | $0.11 B |
On Mar 27th, 2024 the market cap of Agile Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $380.64 B | 34,713,087.81% | ๐บ๐ธ USA |
Pfizer PFE | $157.30 B | 14,345,327.25% | ๐บ๐ธ USA |
Merck MRK | $333.67 B | 30,429,348.22% | ๐บ๐ธ USA |
TherapeuticsMD TXMD | $23.79 M | 2,069.91% | ๐บ๐ธ USA |
Antares Pharma ATRS | $0.95 B | 86,996.73% | ๐บ๐ธ USA |